Telehealth Initiative Enhances Sun Safety in Children of Melanoma Survivors
A recent clinical trial shows that a telehealth program improved sun protection behaviors among children of melanoma survivors, but did not significantly reduce sunburn rates over time.
The trial involved 364 parent-child pairs from melanoma survivor families.
Children in the telehealth intervention reported lower sunburn rates immediately post-intervention.
Long-term sunburn reduction was not achieved, indicating a need for additional strategies.
A clinical trial has revealed that a telehealth intervention aimed at families of melanoma survivors has successfully enhanced sun protection behaviors among children, although it did not lead to a significant reduction in sunburn incidents over time. The study, which took place from April 2020 to October 2023, involved 364 parent-child dyads recruited from cancer registries and clinical databases, focusing on children aged 8 to 17 who had experienced sunburn in the previous year.
Participants were divided into two groups: one receiving the family, lifestyles, actions, and risk education (FLARE) intervention, which combined education on melanoma risk and practical strategies for sun protection, and the other receiving general educational content about health information. Both groups engaged in telehealth education modules over a four-week period.
While the primary analysis indicated no significant difference in the rate of change in sunburn between the two groups, children in the FLARE group reported fewer sunburns during the first assessment following the intervention. Additionally, those who participated in the FLARE program demonstrated a notable improvement in sun-protective behaviors compared to the control group, suggesting that the intervention was effective in promoting safer sun practices.
Despite these positive outcomes, the study found that enhancing sun protection behaviors alone was insufficient to achieve a sustained reduction in sunburn rates among children at higher risk for melanoma. Researchers noted that while the FLARE intervention led to immediate benefits in reported sunburn rates and protective behaviors, the long-term goal of reducing sunburn was not met. This highlights the necessity for further strategies to ensure lasting sun safety among children of melanoma survivors.
Looking ahead, the findings from this trial underscore the importance of continued research and the development of comprehensive approaches that can effectively lower sunburn rates in this vulnerable population. Future studies may explore additional interventions or support systems that could complement the FLARE program to achieve better long-term outcomes.
